Target Audience

This activity was developed for Family Physicians, Allergists, Immunologists, Pediatricians, Pulmonologists, Registered Nurses, Physician Assistants, and Nurse Practitioners.

Goals and Objectives

Upon completion of this activity, participants will demonstrate the ability to:

1. Discuss the different types of adverse reactions to foods.
2. Review an approach to making an accurate diagnosis of food allergy.
3. Explain management strategies for food allergy.

Accreditation and Designation Statement

National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

National Jewish Health designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Disclosure Information Listed for CME Content Development and Approval Committee and Participating Program Faculty

In accordance with the Accreditation Council for Continuing Medical Education, National Jewish Health requires that all program faculty, content developers, CME approval committee, and medical writers in a position to control the content of this activity are expected to disclose any or not significant financial interest or other relationship with any proprietary entity producing health care goods or services, with the exemption of non-profit or governmental organizations and non-health care related companies. Our goal is to ensure that there is no compromise of the ethical relationship that exists between those in a position to control the content of the activity and those attending the activity and their respective professional duties.

Significant financial interest is defined as receiving, or in the past twelve months having received, a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received or expected.

All CME Educational Activities sponsored by National Jewish Health are reviewed by our faculty CME committee to ensure a balanced and evidence-based presentation. Any potential conflict of interest among program faculty has been identified and resolved according to ACCME guidelines.

Faculty Disclosures

In accordance with the Accreditation Council for Continuing Medical Education, National Jewish Health requires that all persons in a position to control the content of a CME activity, including the CME review committee disclose all significant financial interest with commercial interests.

KEY

Dan Atkins, MD
Medical Director, Pediatric Day Program
Division Head, Ambulatory Pediatrics
National Jewish Health
Assistant Professor, Department of Pediatrics
University of Colorado, Denver and Health Sciences Center, Denver, CO
R - Food Allergy & Anaphylaxis Network

David Beuther, MD
Assistant Professor, Department of Medicine
National Jewish Health
R - Merck & Co., Inc.

Ronina Covar, MD
Associate Professor, Department of Medicine
National Jewish Health
C - AstraZeneca, Merck & Co., Inc.
R - AstraZeneca, Ross Products/Abbott Laboratories

Stephen K. Frankel, MD
Department of Medicine
Chief, Division of Critical Care and Hospital Medicine
Assistant Director, Interstitial Lung Disease Program
Associate Professor
National Jewish Health
Has no significant financial interest to report

Mary Ellen King, Ph.D.
Medical Writer
Has no significant financial interest to report

Harold Nelson, MD
Professor, Division of Allergy and Clinical Immunology
Department of Medicine
National Jewish Health
C - Curalogic, Dey Laboratories, Dynavax Technologies, Genentech,GlaxoSmithKline, Johnson & Johnson, Novartis, Schering Plough(Integrated Therapeutics Group)
R - Boehringer, Clinical Therapeutics, Genentech, MediciNova, Inc.,Novartis, Sepracor, Inc., Schering Plough (Integrated Therapeutics Group), Teva Pharmaceutical Industries Ltd., Wyeth
SP - AstraZeneca, GlaxoSmithKline

David Tinkelman, MD
Department of Pediatrics
Vice President, Health Initiatives
National Jewish Health
SP - Boehringer Ingelheim

Richard W. Weber, MD
Professor
Department of Medicine
National Jewish Health
C - AstraZeneca, Genentech, Novartis
R - Eli Lilly and Company, GlaxoSmithKline, MannKind Corporation,Pfizer, Inc.
SP - AstraZeneca, Genentech, Novartis, GlaxoSmithKline

Commercial Support

None, this project was produced and funded by the Office of Professional Education at National Jewish Health.

This downloadable publication is in the PDF format at no cost to you.

Click here if you need the FREE Adobe reader to view this file on a Windows PC, Mac or Linux computer system.